Evidence map›Paper›PMID 29668418›Full record

ArticleRadiology2018

Egesta Lopci, Giorgio Guazzoni, Massimo Lazzeri

Registry-linked trialAbstract readComment
PubMed Publisher
In one paragraph

Article in Radiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05297162 (Diagnostic Performance and Clinical Impact of PSMA PET/CT vs. mpMRI in Patients With a High Suspicion of Prostate Cancer and Previously Negative Biopsy), which is not on this map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05297162 naunknown statusnot on this mapstarted 2022, after this paper: background citation

Diagnostic Performance and Clinical Impact of PSMA PET/CT vs. mpMRI in Patients With a High Suspicion of Prostate Cancer and Previously Negative Biopsy: a Head to Head, Parallel, Prospective Trial (PROSPET-BX)."

TypeinterventionalSponsorIstituto Clinico HumanitasRan2022 to 2025Enrolled128ConditionsProstate CancerArmsPSMA PET/TRUS (trans-rectal or trans-perineal) fusion biopsy
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. The Role of [Cancers · 2022
    Review
  5. Article
  6. PSMA PET-CT: the winner takes it all.European journal of nuclear medicine and molecular imaging · 2021
    Article
  7. CanEuropean journal of nuclear medicine and molecular imaging · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Egesta LopciDepartments of Nuclear Medicine * and Urology.
Giorgio Guazzoni† Humanitas Clinical and Research Hospital, via Manzoni 56, 20089 Rozzano (Milan), Italy.
Massimo Lazzeri† Humanitas Clinical and Research Hospital, via Manzoni 56, 20089 Rozzano (Milan), Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Glutamate Carboxypeptidase IIPositron Emission Tomography Computed TomographyAntigens, SurfaceHumansMagnetic Resonance ImagingMaleProstatic NeoplasmsAntigens, SurfaceFOLH1 protein, humanGlutamate Carboxypeptidase II

Identifiers

PMID29668418

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.